Meta Information
ID:dihexa
Name:
Schema Version:AIM-2.0
Interactions
Target id:
/condition/active-cancer
Target name:
Active or Recent Cancer
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Dihexa potently activates the HGF/c-Met signaling pathway, a known proto-oncogene involved in cell proliferation and metastasis, which could theoretically accelerate the growth of existing malignancies.
Actionable advice:
Avoid completely if you have a current or recent history of cancer.
Target id:
/class/chemotherapy-radiation
Target name:
c-Met Inhibitor Cancer Drugs
Severity:
major
Interaction type:
diminishing
Nature:
absolute
Temporal spacing:
null
Description:
Dihexa directly activates the c-Met receptor, which would counteract the intended therapeutic mechanism of c-Met inhibitor medications (e.g., cabozantinib, crizotinib) used in cancer treatment.
Actionable advice:
Avoid completely while taking c-Met inhibitor medications.
Target id:
/condition/pregnancy
Target name:
Pregnancy
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
The effects of this experimental peptide on fetal development are completely unknown, posing a significant and unacceptable risk to the developing fetus.
Actionable advice:
Avoid completely during pregnancy.
Target id:
/condition/lactation
Target name:
Breastfeeding (Lactation)
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
It is unknown if Dihexa can pass into breast milk or what effects it might have on a nursing infant; therefore, its use is contraindicated.
Actionable advice:
Avoid completely while breastfeeding.
Target id:
/condition/pediatric
Target name:
Pediatric Use
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
The safety and efficacy of Dihexa have not been established in children; its potent effects on growth factor signaling make it unsuitable for use in developing individuals.
Actionable advice:
Do not use in children or adolescents.
Target id:
/dietary/meal
Target name:
Oral Administration with Food
Severity:
major
Interaction type:
diminishing
Nature:
temporal
Temporal spacing:
Hours before target:
2
Hours after target:
2
Description:
If attempting oral administration (not recommended), digestive enzymes (proteases) in the stomach and small intestine will rapidly degrade the Dihexa peptide, rendering it inactive.
Actionable advice:
Avoid oral administration; use transdermal or subcutaneous routes instead.
Target id:
/class/stimulants
Target name:
CNS Stimulants
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Anecdotal reports suggest Dihexa can have stimulating cognitive effects; combining it with other central nervous system stimulants (e.g., amphetamines, modafinil) may lead to overstimulation, anxiety, or jitteriness.
Actionable advice:
Avoid or significantly reduce the dose of other stimulants when using Dihexa.
Target id:
/circadian/sleep
Target name:
Going to Sleep
Severity:
moderate
Interaction type:
adverse
Nature:
temporal
Temporal spacing:
Hours before target:
8
Hours after target:
null
Description:
The potential stimulating effects of Dihexa may interfere with sleep onset and quality if administered too close to bedtime.
Actionable advice:
Avoid taking Dihexa within 8 hours of your planned bedtime.
Target id:
/class/dopaminergic-agents
Target name:
Dopaminergic Medications
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Dihexa's activation of the HGF/c-Met pathway may influence dopaminergic systems; combining it with medications like L-DOPA or dopamine agonists could unpredictably alter their effects or side effect profile.
Actionable advice:
Use with caution and under medical supervision if taking dopaminergic medications.
Target id:
/class/topical-medications-general
Target name:
Other Topical Medications
Severity:
moderate
Interaction type:
adverse
Nature:
temporal
Temporal spacing:
Hours before target:
2
Hours after target:
2
Description:
If using Dihexa with a DMSO carrier for transdermal application, DMSO can dramatically increase the systemic absorption of other topical substances applied to the same area, potentially causing unintended side effects.
Actionable advice:
Do not apply other topical creams or medications to the same skin area within 2 hours of Dihexa/DMSO application.
Target id:
/condition/geriatric
Target name:
Geriatric (Older Adults)
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
While potentially studied for age-related cognitive decline, older adults may have a higher risk of comorbidities (like undiagnosed cancers) and altered drug metabolism, warranting extreme caution with this experimental compound.
Actionable advice:
Use with extreme caution in older adults, preferably under close medical supervision.
Target id:
/biomarker/comprehensive-liver-function-panel
Target name:
Liver Function Panel
Severity:
moderate
Interaction type:
synergistic
Nature:
absolute
Temporal spacing:
null
Description:
As an experimental peptide with uncharacterized metabolic pathways and potential for unknown toxicity, periodic monitoring of liver enzymes (ALT, AST) is a prudent safety measure.
Actionable advice:
Obtain a baseline liver function panel before starting and monitor periodically during use.
Target id:
/class/ace-inhibitors
Target name:
ACE Inhibitors
Severity:
minor
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
As a highly modified analogue of Angiotensin IV, Dihexa could theoretically have unforeseen effects on the renin-angiotensin system, potentially altering the efficacy or side effects of ACE inhibitors.
Actionable advice:
Monitor blood pressure closely when combining with ACE inhibitors.
Target id:
/class/arbs
Target name:
Angiotensin II Receptor Blockers (ARBs)
Severity:
minor
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
As a highly modified analogue of Angiotensin IV, Dihexa could theoretically have unforeseen effects on the renin-angiotensin system, potentially altering the efficacy or side effects of ARBs.
Actionable advice:
Monitor blood pressure closely when combining with ARBs.
Target id:
/circadian/wake
Target name:
Waking Up
Severity:
minor
Interaction type:
synergistic
Nature:
temporal
Temporal spacing:
Hours before target:
null
Hours after target:
1
Description:
Administering Dihexa in the morning aligns its potential cognitive-enhancing and stimulating effects with the body's natural period of activity and wakefulness.
Actionable advice:
Take in the morning to support daytime cognitive function.
Target id:
/intervention/lions-mane-mushroom
Target name:
Lion's Mane Mushroom
Severity:
minor
Interaction type:
synergistic
Nature:
absolute
Temporal spacing:
null
Description:
Dihexa's HGF/c-Met activation may work synergistically with Lion's Mane, which promotes Nerve Growth Factor (NGF), potentially leading to enhanced effects on neurogenesis and synaptic plasticity.
Actionable advice:
May be taken together for potentially complementary neurogenic effects; start with low doses of both.
Target id:
/intervention/noopept
Target name:
Noopept
Severity:
minor
Interaction type:
synergistic
Nature:
absolute
Temporal spacing:
null
Description:
The profound synaptogenic effects of Dihexa may be complemented by nootropics like Noopept that increase levels of BDNF and NGF, potentially enhancing cognitive outcomes through different mechanisms.
Actionable advice:
Use this combination with caution, as the combined cognitive effects are unknown and could be overwhelming.
Target id:
/biomarker/igf-1
Target name:
Insulin-like Growth Factor 1
Severity:
minor
Interaction type:
synergistic
Nature:
absolute
Temporal spacing:
null
Description:
Monitoring IGF-1 provides a general indication of systemic growth factor activity, which may be influenced by potent activators of related pathways like HGF/c-Met.
Actionable advice:
Consider monitoring IGF-1 levels to ensure they remain within a healthy range during long-term use.